IDR-805

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIDR-805
Drug Alias NameMetAP2 inhibitors (IDRTech)MetAP2 inhibitors (Equispharm)methionine aminopeptidase inhibitors (IDRTech)methionine aminopeptidase inhibitors (Equispharm)IDR-804 +[7] 
ClassificationSmall molecules
Mechanisms of ActionCell cycle inhibitorsMethionine aminopeptidase 2 inhibitorsAngiogenesis inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIDRTech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreaPlanet Co LtdIDRTech Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A